# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Canaccord Genuity analyst William Plovanic maintains iRhythm Technologies (NASDAQ:IRTC) with a Buy and lowers the price targ...
Needham analyst David Saxon maintains iRhythm Technologies (NASDAQ:IRTC) with a Buy and raises the price target from $137 to...
iRhythm Technologies (NASDAQ:IRTC) reported quarterly losses of $(1.23) per share which missed the analyst consensus estimate o...
iRhythm Technologies, Inc. ("iRhythm") (NASDAQ:IRTC), a leading digital health care company focused on creating trusted...
U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday.